01.06.2023 • News

PCAS Agrees Sale of Canada Unit to DIC

PCAS has announced that it has decided to sell its Canadian subsidiary to DIC for €88.2 million.

© Getty Images/iStockphoto
© Getty Images/iStockphoto

Japanese chemicals company DIC made the offer for PCAS Canada in early May and the French complex molecules specialist has now accepted following authorization by its board of directors.

As the sale is not subject to any conditions, the transaction is expected to close in the coming days.

PCAS Canada specializes in the synthesis, development and custom manufacturing of ingredients for products used in the electronics industry, as well as producing organic molecules for pharmaceuticals.

Author: Elaine Burridge, Freelance Journalist

Virtual Event

High Performance Food Production
Perfection Starts in the Tank

High Performance Food Production

March 24, 2026 | Optimize your food production with smarter mixing—join the Ystral seminar to discover 20 real-world applications that cut processing times, reduce costs, and boost product quality.

Expert Insights

ADCs for Precision Cancer Therapy
Comprehensive Insights into Antibody–Drug Conjugates

ADCs for Precision Cancer Therapy

Explore how antibody-drug conjugates are reshaping precision cancer therapy and discover what it takes to successfully develop, manufacture, and scale these complex biologics.

Top-Feature

most read

Photo
News • Chemistry

VCI Welcomes US-EU Customs Deal

The German Chemical Industry Association (VCI) welcomes the fact that Ursula von der Leyen, President of the European Commission, and US President Donald Trump have averted the danger of a trade war for the time being.